Today's pre-market stock movers: TSLA, JPM, NVAX, CAG and more
Gainers:
• $Theravance Biopharma(TBPH.US$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $TransGlobe Energy(TGA.US$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock strategic business combination)
• $Clene(CLNN.US$ +5.9% (report significantly improved survival in ALS patients initially treated with CNM-Au8 compared to initially randomized placebo treated participants during the long-term open-label extension of its RESCUE-ALS trial)
• $Marinus Pharmaceuticals(MRNS.US$ +5.4% (entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher for $110 mln)
• $Veracyte(VCYT.US$ +4.2% (new data show that its GSC is highly accurate in re-classifying lung cancer risk)
• $DigitalBridge Group(DBRG.US$ +1.8% (acquires majority stake in GD Towers in partnership with Brookfield (BIP))
Losers:
In reaction to earnings/guidance:
• $LM Ericsson Telephone(ERIC.US$ -9.7% (Telefonaktiebolaget L M missed estimated earnings by 12.5%, reporting an EPS of $0.14 versus an estimate of $0.16.)
• $JPMorgan(JPM.US$ -2.9% (JPMorgan Chase missed estimated earnings by 5.15%, reporting an EPS of $2.76 versus an estimate of $2.91.)
• $Conagra Brands(CAG.US$ -1.1% (Conagra Brands reported fourth-quarter FY22 sales growth of 6.2% year-on-year to $2.91 billion, missing the consensus of $2.93 billion.)
• $Morgan Stanley(MS.US$ -0.9% ( Morgan Stanley said Thursday its second-quarter profit fell 29% from a year ago, reflecting a drop in corporate deal making.)
Select metals/mining stocks trading lower:
• $AngloGold Ashanti(AU.US$ -3.8%, $Gold Fields(GFI.US$ -3.7%, $VanEck Gold Miners Equity ETF(GDX.US$ -2.2%, $Barrick Gold(GOLD.US$ -2.2%, $B2Gold(BTG.US$ -2.1%, $iShares Silver Trust(SLV.US$ -2%, $SPDR Gold ETF(GLD.US$ -1.1%
Select oil/gas related names showing early weakness:
• $TotalEnergies(TTE.US$ -4.3%, $Shell PLC(SHEL.US$ -3.3%, $BP PLC(BP.US$ -3%, $VanEck Oil Services ETF(OIH.US$ -2.4%, $Halliburton(HAL.US$ -2.2%, $ConocoPhillips(COP.US$ -2.1%, $Energy Select Sector SPDR Fund(XLE.US$ -2%, $Schlumberger(SLB.US$ -1.8%, $Phillips 66(PSX.US$ -1.8%, $United States Oil Fund LP(USO.US$ -1.7%
Other news:
• $ContraFect(CFRX.US$ -77.2% (independent DSMB recommends Exebacase Phase 3 DISRUPT Study be stopped)
• $BELLUS Health(BLU.US$ -8.8% (prices offering of 16540541 common shares at $9.25 per common share)
• $VAALCO Energy(EGY.US$ -8.8%(Trans globe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock strategic business combination)
• $Fluence Energy(FLNC.US$ -1.3% (luence and Nine Additional Energy Market Organisations Issue Open Letter to European Policy Makers and the Media regarding the RE Power EU Plan)
Analyst comments:
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
Giovanni Ayala :